Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2010 Financial Results, Guidance for 2011
Date:2/10/2011

tract and period costs related to production.  The reduction in the gross margin rate is due to a $3.9 million provision for XIAFLEX inventory that may expire in 2011 prior to expected future sales to customers, and lower amortization in 2010 of deferred milestone payments, partially offset by the contribution of high margin XIAFLEX product sales and the impact of year-over-year price increases on U.S. Testim revenues.

Research and development spending for the quarter ended December 31, 2010 was $14.0 million, compared to $11.4 million for 2009.  The increase in expense results principally from the commencement of start-up activities related to the phase III XIAFLEX clinical trials for Peyronie's disease and costs related to development of a larger scale XIAFLEX production process.  

Selling, general and administrative costs for the quarter ended December 31, 2010 were $47.0 million, compared to $38.7 million in the comparable 2009 period.  The increase was primarily due to the addition of the sales and reimbursement field force and infrastructure, and promotional and training activity in support of the launch of XIAFLEX for Dupuytren's in the U.S., and higher non-cash stock-based compensation expense.

As of December 31, 2010, Auxilium had $128.2 million in cash, cash equivalents and short-term investments, compared to $142.4 million at September 30, 2010.

2010 Revenue DetailsAuxilium reported the following unaudited net revenues (all amounts in millions of dollars) for the full year 2010: Year EndYear EndIncrease12/31/201012/31/2009 (Decrease)Testim U.S. Revenue

$190.0$152.025%Testim Ex – U.S. & Contract Revenue

3.08.5(64%)Total Testim Revenue

$193.0$160.520%XIAFLEX U.S. Revenue

$14.1-n/aXIAFLEX Contract Revenue

4.33.622%Total XIAFLEX Revenue

$18.4$3.6417%Total Worldwide Revenue

$211.4$164.029%Contract Revenues represent amortization of previously receive
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2010 Results and Conduct Conference Call on Thursday, February 10, 2011
2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
3. VioQuest Pharmaceuticals, Inc Q2/08 Review Issued by Scimitar Equity, LLC
4. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
5. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
6. Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
7. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
8. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
9. Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
10. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
11. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... occurs when the transplant recipient,s immune system identifies the ... was previously thought that T cells, the immune cells ... known as chemokines in order to migrate to the ... of Clinical Investigation , Fadi Lakkis and colleagues at ... chemokine stimulation of T cells is not required for ...
(Date:5/17/2013)... 17, 2013 New interactive ... innovative thought leaders of the medical device industry ... conference and expo, from June 18-20 in ... http://photos.prnewswire.com/prnh/20130517/613829 ) , These ... industry professionals practical presentations and implementable solutions on ...
(Date:5/17/2013)... Men’s skin is biologically different than women’s skin,( says ... been known to react more aggressively when hormones change, and ... puberty, other acne causing factors like P.acnes bacteria and excess ... with unsightly acne scars. Adult acne treatment, Probiotic Action shares ... how to reduce and prevent acne scarring. , In order ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Tooth decay is ... showing active signs of the disease. The World Health Organization ... nearly 100% of adults have cavities. What are the long-term ... is showing a strong connection between the oral bacterial imbalance ... this disease so rampant, yet it is also 100% preventable? ...
Breaking Biology Technology:MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... Calif., Sept. 13 VaxGen,Inc. (Pink Sheets: VXGN) ... commitment to align its cost structure with,its pursuit ... VaxGen is reducing its workforce from 61 ... its monthly cash expenditures used in operating,activities to ...
... Martek Biosciences,Corporation (Nasdaq: MATK ) announced ... Global Life Sciences Conference in New York City. ... the Grand Hyatt in New,York. Peter L. Buzy, ... at,3:00 p.m. Eastern Time. A live audio ...
... Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ) today announced ... Biotech and Medtech Conference,will be webcast live and ... the Company,s website, http://www.millennium.com . (Logo: ... include an overview of the Company, an update ...
Cached Biology Technology:VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives 2Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation 2
(Date:5/16/2013)... to Research Careers) Program has announced the travel ... (SDB) 72nd Annual Meeting in Cancun, Mexico from ... promote the entry of students, postdoctorates and scientists ... basic science community and to encourage the participation ... Meeting. , Awards are given to poster/platform presenters ...
(Date:5/16/2013)... nanoparticles developed at MIT may someday eliminate the ... constantly monitor their blood-sugar levels and inject themselves ... sense glucose levels in the body and respond ... replacing the function of pancreatic islet cells, which ... Ultimately, this type of system could ensure that ...
(Date:5/16/2013)... , May 16, 2013 Integrated ... combination with a custom thin film transistor camera ... forensic quality roll image in the smallest and ... Sherlock, an Appendix F Mobile ID FAP 45, ... 95% reduction in size and weight when compared ...
Breaking Biology News(10 mins):Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3
... major effort to speed up the process of officially ... required to provide Latin descriptions of new species, and ... considered as valid as print publication. The new ... in conjunction with the International Botanical Congress in July, ...
... scientists released a natural enemy of the Asian citrus ... spread of the psyllid, an invasive pest that could devastate ... home landscapes. This is the first time the psyllid,s natural ... Vice Chancellor Dallas Rabenstein and Mark Hoddle ...
... across the country gained a valuable tool last week, ... hand-held device to detect life-threatening bleeding in the brain. ... initiated and funded by the Office of Naval Research ... hematomas soon after an injury, and could be a ...
Cached Biology News:Ave Atque Vale: Botany bids 'hail and farewell' to Latin-only descriptions in 2012 2Ave Atque Vale: Botany bids 'hail and farewell' to Latin-only descriptions in 2012 3UC Riverside scientists release natural enemy of Asian citrus psyllid 2UC Riverside scientists release natural enemy of Asian citrus psyllid 3UC Riverside scientists release natural enemy of Asian citrus psyllid 4Naval technology could be a lifesaver 2
Packaging: package with 500 l Patent/trademark/license (electronic): (r) Registered trademark of Molecular Probes...
... V, is used for protein separation and ... system includes both the mini (18 ml) ... harvesting apparatus, cooling finger, electrode chambers, 10 ... syringe, colored protein sample, 2 vent buttons, ...
...
... B-Phycoerythrin Labeling Kit - NH2 is primarily ... for immunostaining and cellular proteins for tracing. ... has succinimidyl group (NHS), and can easily ... of IgG or other proteins without any ...
Biology Products: